Page last updated: 2024-09-03

vadimezan and Carcinoma, Epidermoid

vadimezan has been researched along with Carcinoma, Epidermoid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hida, T; Hirashima, T; Horai, T; Horio, Y; Kobayashi, K; Nishio, M; Shi, MM; Tamiya, M; Tanii, H; Yamamoto, N	1
Coulthard, T; Sacadura, NT; Seshadri, M	1
Baguley, BC; Cao, Z; Ching, LM; Joseph, WR; Marshall, ES; Mountjoy, KG	1

Trials

1 trial(s) available for vadimezan and Carcinoma, Epidermoid

Article	Year
Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer. Cancer science, 2011, Volume: 102, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Asian People; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Remission Induction; Survival Rate; Tissue Distribution; Treatment Outcome; Xanthones	2011

Article

Year

Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer.

Cancer science, 2011, Volume: 102, Issue:4

Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Asian People; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Remission Induction; Survival Rate; Tissue Distribution; Treatment Outcome; Xanthones

2011

Other Studies

2 other study(ies) available for vadimezan and Carcinoma, Epidermoid

Article	Year
Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging. Angiogenesis, 2011, Volume: 14, Issue:4 Topics: Animals; Area Under Curve; Carcinoma, Squamous Cell; Female; Gadolinium; Head and Neck Neoplasms; Humans; Magnetic Resonance Angiography; Mice; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds; Transplantation, Heterologous; Ultrasonography; Xanthones	2011
Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy. Cancer research, 1999, Feb-01, Volume: 59, Issue:3 Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Lipopolysaccharides; Liver; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; RNA, Messenger; Spleen; Stimulation, Chemical; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones	1999

Article

Year

Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging.

Angiogenesis, 2011, Volume: 14, Issue:4

Topics: Animals; Area Under Curve; Carcinoma, Squamous Cell; Female; Gadolinium; Head and Neck Neoplasms; Humans; Magnetic Resonance Angiography; Mice; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds; Transplantation, Heterologous; Ultrasonography; Xanthones

2011

Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.

Cancer research, 1999, Feb-01, Volume: 59, Issue:3

Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Lipopolysaccharides; Liver; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; RNA, Messenger; Spleen; Stimulation, Chemical; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones

1999